Fluorocholine PET/CT Basket Trial

This is a single-arm, open-label, phase III trial in up to 2000 patients with known or suspected benign or malignant tumors which are known or suspected to be 18F-fluorocholine-avid. Patients will receive regular standard clinical care. The only study-specific procedure will be the administration of 18F-fluorocholine followed by a PET/CT scan. Diagnostic accuracy of 18F-fluorocholine PET/CT will be captured versus a composite clinical, radiological and histopathological standard of truth at follow-up.

NCT Number	NCT04150458
Lead Sponsor	Sir Mortimer B. Davis - Jewish General Hospital
Conditions	Fluorocholine PET/CT
Enrollment	2,000 participants
Start Date	2022-11-30
Primary Completion	2030-01 (estimated)
Study Completion	2030-07 (estimated)
Updated on ClinicalTrials.gov	2024-04-17